Godavari Drugs Ltd. | Income Statement
Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
93,205.20
548,462.60
711,210.50
755,985.20
644,477.60
Cost of Goods Sold (COGS) incl. D&A
73,716.80
482,387.40
651,589.60
685,406.90
579,996.70
Gross Income
19,488.40
66,075.20
59,620.90
70,578.30
64,480.90
SG&A Expense
11,300.60
14,442.40
20,047.80
25,262.00
33,494.90
EBIT
7,948.80
51,003.70
-
-
30,549.30
Unusual Expense
-
-
219.40
330.80
-
Non Operating Income/Expense
986.80
2,840.50
1,357.10
7,518.90
5,923.70
Interest Expense
2,085.50
6,676.20
18,799.10
25,094.40
24,179.80
Pretax Income
7,026.80
47,338.40
21,780.10
27,078.80
13,139.00
Income Tax
8,489.30
10,869.90
8,269.40
8,986.70
4,845.20
Consolidated Net Income
15,516.20
36,468.50
13,510.70
18,092.10
8,293.80
Net Income
15,516.20
36,468.50
13,510.70
18,092.10
8,293.80
Net Income After Extraordinaries
15,516.20
36,468.50
13,510.70
18,092.10
8,293.80
Net Income Available to Common
15,516.20
36,468.50
13,510.70
18,092.10
8,293.80
EPS (Basic)
2.06
4.84
1.79
2.40
1.10
Basic Shares Outstanding
7,530.50
7,530.50
7,530.50
7,530.50
7,530.50
EPS (Diluted)
2.06
4.84
1.79
2.40
1.10
Diluted Shares Outstanding
7,530.50
7,530.50
7,530.50
7,530.50
7,530.50
EBITDA
23,007.10
60,921.30
45,172.80
52,549.10
40,402.60
Other Operating Expense
239.10
629.00
661.90
835.70
436.70
Non-Operating Interest Income
176.80
170.40
530.30
504.40
845.80
About Godavari Drugs
View Profile
